2 appointments in 2 weeks? I reckon it’s a good sign! “…it has...

2 appointments in 2 weeks? I reckon it’s a good sign!

“…it has now matured to the stage where an in-house role make sense.” – The business is growing!

I truly believe this is not a last-minute decision by the Company. We could sense that the outcome from both readout (within 6 months) should be positive.

We have mentioned about Fast Track/potential breakthrough therapy designation from FDA previously.

BUT don’t forget The Land of Down Under. There’s about 1,000 DMD patients in Australia. If the trial result is positive, it will also lead to discuss with TGA for potential marketing approval.

“…At some point, the large companies, whether it’s big pharma or large biotech, they have the ability to sell a drug and to properly commercialise it and to take those approved therapies and bring them to global markets.”

“A biotech company, particularly a small or even a mid-sized biotech company, doesn’t always have the capability of doing it on its own.”

Partnership is just a matter of time.